SAN JOSE, Calif., May 21, 2013 /PRNewswire/ -- RenovoRx (www.renovorx.com) has been named Winner of the prestigious 2013 TiE50 "Top Startup" Award at TiEcon 2013, the world's largest annual convention for entrepreneurs, for its innovation, strong management team and quality of entrepreneurial ideas. RenovoRx was honored on Saturday, May 18^th at the Santa Clara Convention Center.

The TiE50 Awards is a highly influential list of the most enterprising startup companies across five verticals: Internet, Software, Mobile, Energy and Life Sciences. Speaking to a global audience at the awards ceremony during TiEcon 2013, the conference Chairman and President of TiE Silicon Valley, Mr. Venkatesh Shukla, said that "the TiE50 program screened 1142 companies from 24 countries and 50 best-of-breed companies were announced winners."

RenovoRx is one of the only three winning startups in the Life Sciences vertical and was selected through a process including meticulous screening and judging by prominent entrepreneurs, venture capitalists, corporate executives and other domain experts.

"Over the past four years, the TiE50 program gained global acclaim attracting startups from all over the world. TiE50 as a brand has gained much recognition amongst the VC and Angel communities – particularly in the Silicon Valley. About 110 finalists and winners had successful exits," said Program Chair Ram K. Reddy.

"We're honored to receive this award, especially given the caliber of the winning companies," said Marta Gaia Zanchi, RenovoRx's Chief Executive Officer. "To have an organization as TiE, whose name has become globally synonymous with entrepreneurship, recognize us among the most enterprising startups is an acknowledgement of our passion and capital efficient model for developing solutions for targeted delivery of fluids to selected sites in the peripheral vascular system. This award consolidates our success and will serve us well as we prepare to enter the next exciting phase of our company's life."

About RenovoRx
RenovoRx is a privately held medical device company based in Silicon Valley developing solutions for targeted delivery of fluids, including radiopaque material and therapeutic agents, to selected sites in the peripheral vascular system. The ability to deliver these materials to specific visceral organs, safely and without perfusion overlap to other organs, is a central paradigm of RenovoRx's technology. Founded in 2009, RenovoRx is backed by groups of professional angel investors including The Halo Fund, The Angels' Forum, Golden Seeds and Sand Hill Angels. For more information, please visit www.renovorx.com.

About TiE50 and TiEcon
TiE is a global, not-for-profit network of entrepreneurs and professionals dedicated to the advancement of entrepreneurship. TiE50 Awards is TiE Silicon Valley's premier annual awards program contested by thousands of technology startups worldwide. Awards are announced at TiEcon, the world's largest conference for entrepreneurs. TiEcon 2013 attracted 3,700+ attendees from across the world, including CEOs of established companies to first-time entrepreneurs creating new companies, to leading investment professionals and corporate executives. For more information, please visit www.tiecon.org.

SOURCE RenovoRx